The development and manufacture of biopharmaceuticals is a dynamic and rapidly growing industry. By the nature of their production, biopharmaceuticals are highly complex heterogeneous mixtures that require many analytical techniques for characterization and routine testing. As a result, many manufacturers incorporate life cycle management into their respective workflows to take advantage of newer technologies and methodologies to ensure efficacy and patient safety.
In this presentation, we will address the range of chromatographic categories – HPLC, UHPLC, and UPLC – and define the characteristics associated with each. The discussion will continue with several examples of methods transferred from legacy HPLC instrumentation to modern UHPLC and UPLC instruments. We will compare qualitative and quantitative data across each chromatographic class. Resolution, sensitivity, and overall run time will be used as metrics to assess the success of the method transfer to the respective LC platform, to ensure the transferred methods are in line with current acceptance criteria.
- The importance of selecting the correct instrumentation to meet user needs.
- Which parameters influence method transfer from one LC platform to another.
- How workflows can benefit from features such as Multi-flow path technology and Gradient SmartStart when transitioning methods.
Interested in more detail? Watch the related on-demand webinar: http://view6.workcast.net/register?pak=3479247014905635